| scholarly article | Q13442814 |
| P356 | DOI | 10.1164/RCCM.200507-1034OC |
| P8608 | Fatcat ID | release_ezzw3agsgfdtnpnuxn2xp7blhi |
| P932 | PMC publication ID | 2662990 |
| P698 | PubMed publication ID | 16210667 |
| P2093 | author name string | Xiang Xu | |
| George H Caughey | |||
| Donald M McDonald | |||
| Peter Baluk | |||
| Samuel Hawgood | |||
| Paul J Wolters | |||
| Dongji Zhang | |||
| Nigel P Killeen | |||
| Natalya Lyubynska | |||
| P2860 | cites work | Molecular biology and pathogenicity of mycoplasmas | Q24548575 |
| Mast cell-deficient W-sash c-kit mutant Kit W-sh/W-sh mice as a model for investigating mast cell biology in vivo | Q28506160 | ||
| Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4 | Q28513447 | ||
| Surfactant Proteins A and D and Pulmonary Host Defense | Q30049091 | ||
| Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. | Q33731734 | ||
| Roles of innate and adaptive immunity in respiratory mycoplasmosis | Q33757110 | ||
| Mast cells enhance T cell activation: Importance of mast cell-derived TNF. | Q33772139 | ||
| A critical concentration of neutrophils is required for effective bacterial killing in suspension | Q34032375 | ||
| Glycosaminoglycans, airways inflammation and bronchial hyperresponsiveness | Q34305518 | ||
| Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. | Q34367607 | ||
| Cutting edge: mast cell antimicrobial activity is mediated by expression of cathelicidin antimicrobial peptide | Q34531494 | ||
| Building a better heparin | Q35050511 | ||
| Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis | Q35198652 | ||
| Mycoplasma pulmonis infections cause long-lasting potentiation of neurogenic inflammation in the respiratory tract of the rat | Q35819000 | ||
| Mycoplasma pneumoniae and its role as a human pathogen | Q35920629 | ||
| Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice | Q36368668 | ||
| The c-kit ligand, stem cell factor, can enhance innate immunity through effects on mast cells | Q36401371 | ||
| Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/Kit(W-sh) sash mice | Q36503050 | ||
| A link between chronic asthma and chronic infection | Q37874435 | ||
| Tryptase inhibition blocks airway inflammation in a mouse asthma model | Q38523456 | ||
| Mast cell dipeptidyl peptidase I mediates survival from sepsis | Q40553691 | ||
| Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells | Q40744145 | ||
| Stem cell factor and igE-stimulated murine mast cells produce chemokines (CCL2, CCL17, CCL22) and express chemokine receptors. | Q43599001 | ||
| Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model | Q43606196 | ||
| Angiogenesis and remodeling of airway vasculature in chronic inflammation | Q43816379 | ||
| Enhancement of neutrophil infiltration in histidine decarboxylase-deficient mice | Q44182006 | ||
| Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. | Q44306884 | ||
| Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection | Q44640663 | ||
| Tissue distribution of surfactant proteins A and D in the mouse | Q46728552 | ||
| Matrix metalloproteinase-2 and -9 expression increases in Mycoplasma-infected airways but is not required for microvascular remodeling | Q47789429 | ||
| Mycoplasma pneumoniae infection increases airway collagen deposition in a murine model of allergic airway inflammation. | Q47829835 | ||
| Mast cell phagocytosis of FimH-expressing enterobacteria. | Q54640184 | ||
| Impaired mast cell-dependent natural immunity in complement C3-deficient mice | Q59049556 | ||
| Critical protective role of mast cells in a model of acute septic peritonitis | Q59072203 | ||
| Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α | Q59092114 | ||
| Neutrophil recruitment by tumor necrosis factor from mast cells in immune complex peritonitis | Q67972579 | ||
| Definition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection | Q68028746 | ||
| Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma | Q72399045 | ||
| A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation | Q73306812 | ||
| Surfactant protein A binds Mycoplasma pneumoniae with high affinity and attenuates its growth by recognition of disaturated phosphatidylglycerols | Q80894458 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pneumonia | Q12192 |
| mast cell | Q191989 | ||
| P304 | page(s) | 219-225 | |
| P577 | publication date | 2005-10-06 | |
| P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
| P1476 | title | Mast cells protect mice from Mycoplasma pneumonia | |
| P478 | volume | 173 |
| Q36688774 | A Pulmonary Perspective on GASPIDs: Granule-Associated Serine Peptidases of Immune Defense |
| Q37326649 | A novel IL-17-dependent mechanism of cross protection: respiratory infection with mycoplasma protects against a secondary listeria infection |
| Q36630944 | Approaches for analyzing the roles of mast cells and their proteases in vivo |
| Q37297985 | Cathepsin L protects mice from mycoplasmal infection and is essential for airway lymphangiogenesis. |
| Q34437813 | Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae |
| Q53736876 | Dermal mast cells reduce progressive tissue necrosis caused by subcutaneous infection with Streptococcus pyogenes in mice |
| Q51704472 | Expression of MIG/CXCL9 in cystic fibrosis and modulation of its activities by elastase of Pseudomonas aeruginosa. |
| Q36788220 | Inflammatory response of mast cells during influenza A virus infection is mediated by active infection and RIG-I signaling |
| Q34160672 | Lymphatics in lung disease |
| Q55064943 | Mast Cells Exert Anti-Inflammatory Effects in an IL10-/- Model of Spontaneous Colitis. |
| Q34628122 | Mast Cells in Lung Homeostasis: Beyond Type I Hypersensitivity |
| Q36627796 | Mast cell TNF receptors regulate responses to Mycoplasma pneumoniae in surfactant protein A (SP-A)-/- mice |
| Q33336048 | Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin |
| Q35077675 | Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms |
| Q34627778 | Mast cell tryptases and chymases in inflammation and host defense |
| Q33597224 | Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice |
| Q35747350 | Mast cell-orchestrated immunity to pathogens |
| Q38723163 | Mast cells and their activation in lung disease |
| Q87578686 | Mast cells are activated by Staphylococcus aureus in vitro but do not influence the outcome of intraperitoneal S. aureus infection in vivo |
| Q42215468 | Mast cells impair host defense during murine Streptococcus pneumoniae pneumonia |
| Q37841659 | Mast cells in health and disease |
| Q36756839 | Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4. |
| Q35329165 | Mast cells play an important role in chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway |
| Q33952659 | Mast cells protect against airway Mycoplasma pneumoniae under allergic conditions |
| Q38079832 | Mast cells: multitalented facilitators of protection against bacterial pathogens |
| Q36281317 | Mycoplasma pneumoniae CARDS toxin elicits a functional IgE response in Balb/c mice. |
| Q36228230 | Neutrophil histamine contributes to inflammation in mycoplasma pneumonia |
| Q35767129 | Plasticity in mast cell responses during bacterial infections |
| Q36539857 | Potential effector and immunoregulatory functions of mast cells in mucosal immunity |
| Q37295072 | Pro-atherogenic lung and oral pathogens induce an inflammatory response in human and mouse mast cells |
| Q35566385 | Regulation of hepatocyte growth factor in mice with pneumonia by peptidases and trans-alveolar flux |
| Q38019500 | Role and relevance of mast cells in fungal infections |
| Q35790205 | Strain-dependent induction of neutrophil histamine production and cell death by Pseudomonas aeruginosa |
| Q50068978 | The contribution of mast cells to bacterial and fungal infection immunity |
| Q37829600 | The effect of bacterial, viral and fungal infection on mast cell reactivity in the allergic setting |
| Q37952138 | The impact of bacterial infection on mast cell degranulation |
| Q36669253 | Unique populations of lung mast cells are required for antigen-mediated bronchoconstriction. |
| Q36769694 | Update in critical care 2006. |
Search more.